-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q3 2024.
- Lyell Immunopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $5.92M, a 27.7% decline year-over-year.
- Lyell Immunopharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $13.1M, a 7.73% increase year-over-year.
- Lyell Immunopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $12.4M, a 214% increase from 2022.
- Lyell Immunopharma, Inc. annual Nonoperating Income (Expense) for 2022 was $3.94M.
- Lyell Immunopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$35.4M, a 575% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)